Geode Capital Management
ENVB icon

Geode Capital Management’s Enveric Biosciences ENVB Stock Holding History

Geode Capital Management’s Portfolio ENVB Stock Details ENVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.3K Sell
11,794
-20,355
-63% -$48.9K ﹤0.01% 4390
2026
Q1 		$62.4K Buy
+32,149
New +$87.7K ﹤0.01% 4262
2025
Q4 		– Sell
-2,376
Closed -$18.2K – 4497
2025
Q3 		$18.2K Buy
2,376
+29
+1% +$380 ﹤0.01% 4423
2025
Q2 		$34.1K Buy
2,347
+134
+6% +$2.03K ﹤0.01% 4283
2025
Q1 		$36.9K Buy
2,213
+1,010
+84% +$35K ﹤0.01% 4244
2024
Q4 		$77.6K Sell
1,203
-8
-0.7% -$581 ﹤0.01% 4159
2024
Q3 		$103K Buy
1,211
+963
+388% +$88.6K ﹤0.01% 4093
2024
Q2 		$27.7K Buy
248
+175
+240% +$26.4K ﹤0.01% 4400
2024
Q1 		$13.1K Hold
73
– – ﹤0.01% 4529
2023
Q4 		$17.1K Hold
73
– – ﹤0.01% 4538
2023
Q3 		$30.3K Buy
+73
New +$32.9K ﹤0.01% 4534
2022
Q3 		– Sell
-23
Closed -$43K – 5032
2022
Q2 		$43K Buy
23
+4
+21% +$8.51K ﹤0.01% 4808
2022
Q1 		$54K Hold
19
– – ﹤0.01% 4789
2021
Q4 		$154K Buy
19
+6
+46% +$84.3K ﹤0.01% 4588
2021
Q3 		$238K Buy
13
+2
+18% +$38.8K ﹤0.01% 4366
2021
Q2 		$235K Buy
11
+4
+57% +$85.7K ﹤0.01% 4274
2021
Q1 		$193K Buy
+7
New +$245K ﹤0.01% 4120
2020
Q4 		– Hold
0
– -$14K – 4276
2020
Q3 		– Hold
0
– – – 4134
2020
Q2 		– Hold
0
– – – 4078
2020
Q1 		– Hold
0
– – – 4080
2019
Q4 		– Hold
0
– – – 4140
2019
Q3 		– Hold
0
– – – 4075

Other funds holding ENVB

SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management's ENVB Position: Q2 2026 in Review

Geode Capital Management reduced its Enveric Biosciences (ENVB) stake by 63% in Q2 2026, selling an estimated $48.9K and leaving 11,794 shares worth $16.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4390.

Geode Capital Management first reported a position in ENVB in Q1 2021 and has held it in 17 quarters since. The position peaked at $238K in Q3 2021. 24 funds tracked by Wall St. Rank hold ENVB as of Q2 2026.

  • Geode Capital Management held 11,794 shares of Enveric Biosciences worth $16.3K as of Q2 2026.
  • Geode Capital Management sold 20,355 Enveric Biosciences shares in Q2 2026, an estimated $48.9K.
  • Enveric Biosciences made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4390 holding.
  • Geode Capital Management first reported a position in Enveric Biosciences in Q1 2021 and has held it in 17 quarters since.
  • Geode Capital Management's Enveric Biosciences position peaked at $238K in Q3 2021.
  • 24 funds tracked by Wall St. Rank held Enveric Biosciences as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.